Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT03040128
Eligibility Criteria:
Inclusion criteria:
1. Age 18-80 yo
2. Acute neurological deficit with corresponding ICH noted on head CT
3. Glasgow Coma Scale (GCS) \> 8
4. Onset of symptoms within 12 hrs
5. \< 30 ml of blood noted on initial CTH (30 ml hematoma volume is a noted independent marker between good and poor clinical outcome)
6. ICH score \< 3
7. English/ Spanish speaking
Exclusion Criteria:
1. Allergy to tetracycline and tetracycline analogues
2. Pregnancy or suspected pregnancy
3. Hepatic and/or renal insufficiency (LFTs 3x greater than upper limit of normal; creatinine \> 2 mg/dL)
4. Thrombocytopenia (plt count \< 75,000)
5. History of intolerance to minocycline
6. Baseline modified Rankin score \> 1
7. Stuporous or comatose (GCS \< 8)
8. Presence of concomitant serious illness that would confound study, including serious psychiatric disease or prior suicide attempts.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03040128
Study Brief:
Protocol Section:
NCT03040128